调神针刺法治疗特发性耳鸣的随机对照试验

注册号:

Registration number:

ChiCTR2300070302 

最近更新日期:

Date of Last Refreshed on:

2023-05-28 10:52:29 

注册时间:

Date of Registration:

2023-04-08 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

调神针刺法治疗特发性耳鸣的随机对照试验

Public title:

Efficacy of Acupuncture versus Sham Acupuncture in Idiopathic Tinnitus: A Randomized Controlled Trial

注册题目简写:

English Acronym:

研究课题的正式科学名称:

调神针刺法治疗特发性耳鸣的随机对照试验

Scientific title:

Efficacy of Acupuncture versus Sham Acupuncture in Idiopathic Tinnitus: A Randomized Controlled Trial

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

付渊博 

研究负责人:

付渊博 

Applicant:

Yuanbo Fu 

Study leader:

Yuanbo Fu 

申请注册联系人电话:

Applicant telephone:

+86 18701468963

研究负责人电话:

Study leader's
telephone:

+86 18701468963

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

fuyuanbosir@126.com

研究负责人电子邮件:

Study leader's E-mail:

fuyuanbosir@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

首都医科大学附属北京中医医院

研究负责人通讯地址:

首都医科大学附属北京中医医院

Applicant address:

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University

Study leader's address:

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

首都医科大学附属北京中医医院

Applicant's institution:

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University

研究负责人所在单位:

首都医科大学附属北京中医医院

Affiliation of the Leader:

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2023BL02-020-02

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

首都医科大学附属北京中医医院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2023-03-16 00:00:00

伦理委员会联系人:

刘声

Contact Name of the ethic committee:

Sheng Liu

伦理委员会联系地址:

首都医科大学附属北京中医医院

Contact Address of the ethic committee:

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 10 87906734

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

首都医科大学附属北京中医医院

Primary sponsor:

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University

研究实施负责(组长)单位地址:

北京市东城区美术馆后街23号

Primary sponsor's address:

23 Art Gallery Back Street, Dongcheng District, Beijing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京市

市(区县):

东城区

Country:

China

Province:

Beijing

City:

Dongcheng District

单位(医院):

首都医科大学附属北京中医医院

具体地址:

美术馆后街23号

Institution
hospital:

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University

Address:

23 Art Gallery Back Street

经费或物资来源:

Source(s) of funding:

self-raised

研究疾病:

特发性耳鸣  

Target disease:

idiopathic tinnitus

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

基于循证医学原则,采用随机对照试验方法,对将来自首都医科大学附属北京中医医院针灸科门诊的特发性耳鸣患者90例,随机分组后进行针刺与假针刺治疗,评价针刺疗法治疗特发性耳鸣的疗效。为针刺治疗特发性耳鸣提供循证医学证据。  

Objectives of Study:

A randomized controlled trial was used to evaluate the efficacy of acupuncture therapy in the treatment of idiopathic tinnitus in 90 patients with idiopathic tinnitus from the outpatient clinic of the Department of Acupuncture and Moxibustion of Beijing Hospital of Traditional Chinese Medicine affiliated to Capital Medical University. To provide evidence-based medical evidence for acupuncture for idiopathic tinnitus.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1. 合并有心、肝、肺、肾、血液等其他系统严重疾病者;
2. 不能配合治疗或依从性差患者;
3. 妊娠或哺乳期妇女。
4. 影像学检查提示合并耳部肿瘤者。

Exclusion criteria:

1. Those with serious diseases of the heart, liver, lungs, kidneys, blood and other systems;
2. Patients who cannot cooperate with treatment or have poor compliance;
3. Pregnant or lactating women.
4. Imaging examination showed ear tumors.

研究实施时间:

Study execute time:

From 2023-04-07 00:00:00 To 2024-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-04-07 00:00:00 To 2024-12-31 00:00:00

干预措施:

Interventions:

组别:

针刺组

样本量:

45

Group:

Acupuncture group

Sample size:

干预措施:

针刺

干预措施代码:

Intervention:

Acupuncture

Intervention code:

组别:

假针组

样本量:

45

Group:

Sham acupuncture group

Sample size:

干预措施:

假针

干预措施代码:

Intervention:

Sham acupuncture

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

北京市 

市(区县):

东城区 

Country:

China

Province:

Beijing

City:

Dongcheng

单位(医院):

首都医科大学附属北京中医医院 

单位级别:

三级甲等 

Institution
hospital:

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

耳鸣致残量表

指标类型:

主要指标

Outcome:

tinnitus handicap inventory

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

耳鸣视觉模拟评分量表

指标类型:

次要指标

Outcome:

Visual analogue scale

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

汉密尔顿焦虑量表

指标类型:

次要指标

Outcome:

Hamilton Anxiety Scale

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

汉密尔顿抑郁量表

指标类型:

次要指标

Outcome:

Hamilton Depression Scale

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血清五羟色胺

指标类型:

次要指标

Outcome:

5-Hydroxytryptamine

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血清γ-氨基丁酸

指标类型:

次要指标

Outcome:

gamma-aminobutyric acid

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血清脑源性神经营养因子

指标类型:

次要指标

Outcome:

brain-derived neurotrophic factor

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 65 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

由专业的方法学人员把估算的样本含量输入PEMS 3.1统计软件包, 得出顺序号、随机种子数、分组结果, 制作随机卡片, 放入不透光信封密封。

Randomization Procedure (please state who generates the random number sequence and by what method):

Professional methodologists input the estimated sample content into the PEMS 3.1 statistical software package, obtain the sequence number, random seed number, grouping results, make random cards, and put them into opaque envelope seals.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

基于针刺操作的特殊性研究者及操作者均知道患者所处的组别, 患者无法分辨出针刺治疗组与非穴位浅刺组的区别;针刺组用A组表示,假针组用B组表示,从而更好的对统计者施盲。在进行统计处理前,所有数据将均由专人进行保管,数据统计结束时才会进行揭盲。为最大限度保证盲法的成功率,两组患者在不同的时间和诊室接受治疗,没有交流的机会,在治疗第4周向患者提问进行盲法成功率的评价。

Blinding:

Based on the particularity of acupuncture operation, both the investigator and the operator knew the group in which the patient was located, and the patient could not distinguish the difference between the acupuncture treatment group and the non-acupuncture group. The acupuncture group was represented by group A and the sham needle group by group B, so as to better blind the statisticians. All data will be kept by a special person before statistical processing, and blinding will be carried out at the end of the statistics. In order to maximize the success rate of blinding, the two groups of patients received treatment at different times and consultation rooms, did not have the opportunity to communicate, and asked questions to patients at the 4th week of treatment to evaluate the success rate of blinding.

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

研究项目根据研究进程选择具体方式公开原始数据

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

The research project chooses a specific method according to the research process to disclose the original data

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

本研究产生的数据将由两名数据录入员进行双录入。将根据研究内容编写数据录入指南,并在数据录入前,对数据录入员进行专门的录入培训。数据录入员根据录入指南进行数据录入。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

The data generated in this study will be double-entered by two data entry clerks. A data entry guide will be compiled based on the research content, and special entry training will be provided to data entry staff before data entry. The data entry clerk performs data entry according to the entry guide.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2023-04-08 22:24:05